Susceptibility to COVID ‐19 in patients treated with antimalarials: a population based study in Emilia‐Romagna, Northern Italy
ConclusionsOur study did not support the prophylactic use of antimalarials for COVID ‐19.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Carlo Salvarani,
Pamela Mancuso,
Federica Gradellini,
Nilla Viani,
Paolo Pandolfi,
Massimo Reta,
Giuliano Carrozzi,
Gilda Sandri,
Gianluigi Bajocchi,
Galli Elena,
Francesco Muratore,
Luigi Boiardi,
Nicol ò Pipitone,
Giulia Cassone,
Stefania Tags: BRIEF REPORT Source Type: research
More News: Arthritis | Autoimmune Disease | Coronavirus | COVID-19 | Hydroxychloroquine | Italy Health | Respiratory Medicine | Rheumatology | SARS | Statistics | Study